Fiera Capital Corp Biomarin Pharmaceutical Inc Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$74.43 - $92.22 $521,679 - $646,369	7,009 Added 1.14%	622,953 $51.3 Million
Q1 2024 Aug 22, 2024	SELL	$83.81 - $99.0 $587,424 - $693,891	-7,009 Reduced 1.13%	615,944 $53.8 Million
Q1 2024 May 01, 2024	SELL	$83.81 - $99.0 $3.26 Million - $3.85 Million	-38,923 Reduced 5.94%	615,944 $53.8 Million
Q4 2023 Aug 22, 2024	BUY	$76.22 - $98.51 $482,167 - $623,174	6,326 Added 0.98%	654,867 $63.1 Million
Q4 2023 Feb 08, 2024	BUY	$76.22 - $98.51 $482,167 - $623,174	6,326 Added 0.98%	654,867 $63.1 Million
Q3 2023 Aug 22, 2024	BUY	$85.07 - $94.48 $2.18 Million - $2.42 Million	25,588 Added 4.11%	648,541 $57.4 Million
Q3 2023 Nov 09, 2023	BUY	$85.07 - $94.48 $17.5 Million - $19.5 Million	206,012 Added 46.55%	648,541 $57.4 Million
Q2 2023 Aug 09, 2023	SELL	$86.68 - $100.3 $699,074 - $808,919	-8,065 Reduced 1.79%	442,529 $38.4 Million
Q1 2023 Apr 26, 2023	SELL	$87.74 - $117.27 $922,498 - $1.23 Million	-10,514 Reduced 2.28%	450,594 $43.8 Million
Q4 2022 Feb 08, 2023	SELL	$80.93 - $108.63 $20,556 - $27,592	-254 Reduced 0.06%	461,108 $47.7 Million
Q3 2022 Nov 03, 2022	SELL	$82.16 - $96.94 $344,414 - $406,372	-4,192 Reduced 0.9%	461,362 $36.9 Million
Q2 2022 Aug 10, 2022	SELL	$71.48 - $86.85 $816,873 - $992,521	-11,428 Reduced 2.4%	465,554 $38.6 Million
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $31.5 Million - $39.2 Million	423,444 Added 790.92%	476,982 $36.8 Million
Q4 2021 Feb 08, 2022	BUY	$71.72 - $91.47 $21,157 - $26,983	295 Added 0.55%	53,538 $4.73 Million
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $46.3 Million - $52.9 Million	-619,183 Reduced 92.08%	53,243 $4.12 Million
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $1.72 Million - $1.93 Million	-22,736 Reduced 3.27%	672,426 $82.9 Million
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $882,561 - $1.07 Million	-11,810 Reduced 1.67%	695,162 $52.5 Million
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $166,785 - $207,189	-2,297 Reduced 0.32%	706,972 $62 Million
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $15.5 Million - $28.3 Million	215,865 Added 43.75%	709,269 $54 Million
Q2 2020 Aug 07, 2020	SELL	$79.55 - $124.22 $138,735 - $216,639	-1,744 Reduced 0.35%	493,404 $60.9 Million
Q1 2020 May 08, 2020	BUY	$71.37 - $96.85 $8 Million - $10.9 Million	112,035 Added 29.24%	495,148 $41.8 Million
Q4 2019 Feb 06, 2020	SELL	$64.27 - $86.37 $1.4 Million - $1.88 Million	-21,761 Reduced 5.37%	383,113 $32.4 Million
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $26 Million - $32.8 Million	385,861 Added 2029.46%	404,874 $27.3 Million
Q2 2019 Aug 12, 2019	BUY	$80.35 - $93.9 $444,978 - $520,018	5,538 Added 41.1%	19,013 $1.63 Million
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $301,772 - $353,454	3,584 Added 36.23%	13,475 $1.2 Million
Q4 2018 Feb 12, 2019	BUY	$80.14 - $106.07 $140,004 - $185,304	1,747 Added 21.45%	9,891 $842,000
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $293,687 - $330,586	3,127 Added 62.33%	8,144 $789,000
Q2 2018 Aug 02, 2018	BUY	$76.01 - $99.03 $65,444 - $85,264	861 Added 20.72%	5,017 $473,000
Q1 2018 May 11, 2018	BUY	$77.67 - $92.63 $134,446 - $160,342	1,731 Added 71.38%	4,156 $337,000
Q4 2017 Feb 09, 2018	SELL	$80.76 - $95.13 $6,460 - $7,610	-80 Reduced 3.19%	2,425 $216,000
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $201,903 - $237,849	2,505	2,505 $233,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account